Synthetic Biologics Inc (NYSEMKT:SYN) And Enterome Bioscience Collaborated On Microbiome Research

Boston, MA 06/10/2014 (wallstreetpr) – Synthetic Biologics Inc (NYSEMKT:SYN) and Enterome Bioscience SA on June 10, 2014 announced that the two companies have entered into an agreement for conducting metagenomic research particularly on the effects of beta-lactam antibiotics. As part of the agreement, the two companies will study the effects of the aforementioned antibiotics on […]

Stock Peview: CollabRx Inc (NASDAQ:CLRX); China Digital TV Holding Co., Ltd. (ADR) (NYSE:STV) And Synthetic Biologics Inc (NYSEMKT:SYN)

Boston, MA 03/20/2014 (wallstreetpr) – Taglich Brothers, a New York based investment research firm has started coverage on CollabRx Inc (NASDAQ:CLRX). The firm’s analyst Juan Noble has placed a speculative buy rating on the company while assigning a price target of $10 for the period of next one year. This price target represents a potential […]

Analysts of Ascendiant Capital Markets cover Synthetic Biologics Inc (NYSEMKT:SYN)

Boston, MA 07/16/2013 (wallstreetpr) – Ascendiant Capital Markets provided coverage in the shares of the Synthetic Biologics Inc (NYSEMKT:SYN) on a research note issued for investors on Tuesday. The report said that Synthetic Biologics was in collaboration with Intrexon Corporation, the company’s last venture, with the CEO Randal J Kirk. The vision with which Intrexon has […]